These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21547884)

  • 1. Minimal inspiratory flow from dry powder inhalers according to a biphasic model of pressure vs. flow relationship.
    Kanabuchi K; Kondo T; Tanigaki T; Tajiri S; Hayama N; Takahari Y; Iwao K
    Tokai J Exp Clin Med; 2011 Apr; 36(1):1-4. PubMed ID: 21547884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between inspiratory pressure and flow through dry powder inhaler available in Japan].
    Kondo T; Tanigaki T; Tazaki G; Watanabe H; Ishii H; Tsunoda T; Uruma T
    Arerugi; 2010 Aug; 59(8):950-5. PubMed ID: 20820136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of inspiratory flow for the selection of the inhalation treatment device for asthma and COPD].
    Plavec D; Gluncić TJ; Gudelj I; Mise K
    Lijec Vjesn; 2012; 134(3-4):84-9. PubMed ID: 22768682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
    Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A STUDY OF INSPIRATORY RESISTANCE OF DRY POWDER INHALER OF AGENTS FOR ASTHMA CONTROL].
    Suda S; Konno R; Kurosawa H; Tamura G
    Arerugi; 2016 Jul; 65(7):932-6. PubMed ID: 27545059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
    Droszcz W; Droscez P
    Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs).
    Terzano C; Oriolo F
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2708-2716. PubMed ID: 28678314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventolin Diskus and Inspyril Turbuhaler: an in vitro comparison.
    Broeders ME; Molema J; Burnell PK; Folgering HT
    J Aerosol Med; 2005; 18(1):74-82. PubMed ID: 15741776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow and inspiratory pressure characteristics of In-Check(tm) and training whistles].
    Kondo T; Tanigaki T; Kato S; Tazaki G; Watanabe H; Tsunoda T; Uruma T
    Arerugi; 2012 Jun; 61(6):813-9. PubMed ID: 22868521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
    Amirav I; Newhouse MT; Mansour Y
    Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
    Broeders ME; Molema J; Hop WC; Folgering HT
    J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers.
    Broeders ME; Molema J; Vermue NA; Folgering HT
    Eur Respir J; 2001 Nov; 18(5):780-3. PubMed ID: 11757627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
    Grant AC; Walker R; Hamilton M; Garrill K
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent deterioration of peak inspiratory flow with two kinds of dry powder corticosteroid inhalers (Diskus and Turbuhaler) and relationships with asthma control.
    Baba K; Tanaka H; Nishimura M; Yokoe N; Takahashi D; Yagi T; Yamaguchi E; Maeda Y; Muto T; Hasegawa T
    J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):293-301. PubMed ID: 22047450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
    Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
    Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Teaching the inhalation manoeuvre to asthmatic children by means of visual feedback].
    Kamin W; Kreplin A
    Pneumologie; 2007 Mar; 61(3):150-6. PubMed ID: 17342574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhalation immediately before inhalation optimizes dry powder inhaler use.
    Kondo T; Hibino M; Tanigaki T; Ohe M; Kato S
    J Asthma; 2015; 52(9):935-9. PubMed ID: 26513654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of Turbuhaler dry powder inhaler in Japanese asthma--measurement of peak inspiratory flow when using Turbuhaler].
    Kaneko N; Narushima M; Tanaka K; Suzuki H
    Arerugi; 1996 Jul; 45(7):649-54. PubMed ID: 8831169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD.
    Chetta A; Yorgancioglu A; Scuri M; Barile S; Guastalla D; Dekhuijzen PNR
    BMC Pulm Med; 2021 Feb; 21(1):65. PubMed ID: 33632183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.